Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy. By mapping each patient's unique brain wave patterns, the ...
M107 is the first potential disease-modifying drug for the treatment of gastroparesis -- M107's mechanism of action has been shown to shift pro-inflammatory M1 macrophages towards M2 anti-inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback